CHELSEA CLOKE: Open Payments
NPI 1164020939 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $119 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $93 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $26 |
| Travere Therapeutics, Inc. | 1 | $23 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
Products named: IBSRELA, ULTOMIRIS, OXLUMO, FABRAZYME.
Industry payments across MI — which companies pay providers there.
